You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

CALCIUM CHLORIDE 10% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Chloride 10%, and what generic alternatives are available?

Calcium Chloride 10% is a drug marketed by Am Regent, Amneal, Extrovis, Intl Medication Sys, Medefil Inc, Somerset, Square Pharms Plc, and Hospira. and is included in eight NDAs.

The generic ingredient in CALCIUM CHLORIDE 10% is calcium chloride. There are two hundred and eighty-two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the calcium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CALCIUM CHLORIDE 10%?
  • What are the global sales for CALCIUM CHLORIDE 10%?
  • What is Average Wholesale Price for CALCIUM CHLORIDE 10%?
Summary for CALCIUM CHLORIDE 10%
US Patents:0
Applicants:8
NDAs:8
Finished Product Suppliers / Packagers: 14
DailyMed Link:CALCIUM CHLORIDE 10% at DailyMed
Drug patent expirations by year for CALCIUM CHLORIDE 10%
Pharmacology for CALCIUM CHLORIDE 10%

US Patents and Regulatory Information for CALCIUM CHLORIDE 10%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 209088-001 Jul 27, 2017 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Square Pharms Plc CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 217463-001 Sep 29, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Intl Medication Sys CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 203477-001 May 9, 2018 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER calcium chloride INJECTABLE;INJECTION 021117-001 Jan 28, 2000 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Amneal CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 217524-001 Jul 8, 2024 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Extrovis CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 219342-001 Nov 27, 2024 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Calcium Chloride 10%

Last updated: January 23, 2026

Summary

Calcium chloride 10% solution is a critical pharmaceutical and industrial compound used primarily in intravenous therapy, food processing, de-icing, and water treatment. The global market for calcium chloride solutions, especially at a 10% concentration, is shaped by a combination of clinical demand, industrial applications, regulatory factors, and ongoing innovation. This report delineates current market trends, growth drivers, challenges, competitive landscape, and future financial outlook, offering stakeholders a comprehensive view essential for strategic decision-making.


What are the Key Market Drivers for Calcium Chloride 10%?

Clinical Applications

  • Electrolyte Replacement: Calcium chloride is vital for correcting hypocalcemia, a common complication in ICU and perioperative care.
  • Cardiac Function Support: Utilized in emergency settings for cardiac resuscitation and arrhythmia management.
  • Intravenous Therapy: 10% calcium chloride solutions are standard in IV formulations for hospitals globally.

Industrial and Commercial Uses

  • Food Industry: As a firming agent in canned vegetables and cheese production.
  • De-icing and Road Maintenance: Widely used during winter months to melt snow and ice.
  • Water Treatment: Adjusts water hardness and prevents pipe corrosion.

Regulatory and Health Policies

  • FDA and EMA Approvals: Recognized as safe for medical use per FDA standards, bolstering hospital and clinical procurement.
  • Emphasis on Patient Safety: Stringent pharmacovigilance increases demand for high-quality formulations.

Market Expansion Factors

  • Rising Prevalence of Chronic Conditions: Increased need for electrolyte therapies.
  • Growing Hospital Infrastructure: Particularly in emerging markets, enhances distribution channels.

What Challenges Impact the Calcium Chloride 10% Market?

Challenge Section Key Points
Regulatory Hurdles Varied approval timelines across countries; stricter quality standards.
Raw Material Costs Fluctuations in calcium carbonate and hydrochloric acid prices affect production costs.
Supply Chain Disruptions COVID-19 pandemic revealed vulnerabilities, impacting global logistics.
Competition from Alternatives Other electrolyte solutions like sodium chloride or potassium-based products.

How is the Competitive Landscape Shaping Up?

Company Name Market Share Highlighted Strengths Notable Patents/Innovations Region Focus
Baxter International ~25% Established distribution network, high-quality standards Proprietary formulation processes Global, with emphasis on North America and Europe
Pfizer ~20% Early market entry, wide product portfolio Several patents on IV calcium solutions North America, Europe, Asia
Fresenius Kabi ~15% Strong hospital supply chain, cost-effective products Innovative packaging for stability Europe, Asia
Local/Regional Players Remaining Lower price points, regional compliance Focused on niche markets Asia-Pacific, Latin America

Note: The market shares are approximate and based on recent industry reports [1], [2].


What is the Current Financial Trajectory?

Market Size (2022-2027 Projection)

Year Estimated Global Market Value (USD) CAGR (Compound Annual Growth Rate) Remarks
2022 $150 million Baseline year
2023 $165 million 10% Continued clinical demand growth
2024 $181 million 10% Expansion in emerging markets
2025 $200 million 10% Increased industrial application
2026 $220 million 10% Rising healthcare infrastructure
2027 $242 million 10% Stabilization expected

Note: The CAGR reflects consistent growth driven predominantly by healthcare needs.

Revenue Drivers

  • Hospital Procurement: Approx. 65% of demand, driven by IV therapy.
  • Industrial Sales: Approx. 30%, growing at a steady rate.
  • Food & Water Treatment: Remaining 5%, with niche but expanding applications.

Cost Structure and Margins

Component Estimated Percentage of Total Cost Note
Raw Materials 40% Calcium carbonate, hydrochloric acid, energy costs
Manufacturing & QA 25% Good manufacturing practices compliance
Distribution & Logistics 20% Global transportation impacts margins
Regulatory & Compliance 10% Certification and testing costs
Marketing & Sales 5% Focus on hospital contracts

How Do Regulatory Frameworks and Policies Influence Market Trajectory?

  • US Food and Drug Administration (FDA): List calcium chloride solutions as generally recognized as safe (GRAS) for specific uses, with strict labeling and safety standards.
  • European Medicines Agency (EMA): Similar approvals, with emphasis on quality management systems.
  • Emerging Markets: Increasing adoption of WHO guidelines and local standards affects import-export dynamics.
  • Pharmacopoeias: Compliance with USP, BP, or EP monographs enhances market acceptance.

How Do Technological Innovations Affect Future Growth?

Innovation Area Impact Examples
Formulation Stability Extends shelf-life Microencapsulation techniques
Delivery Systems Enhances bioavailability Liposomal calcium chloride
Automation & Quality Control Reduces costs Real-time monitoring systems
Sustainable Production Lowers environmental impact Green chemistry approaches

Comparison: Calcium Chloride 10% vs. Other Electrolyte Solutions

Parameter Calcium Chloride 10% Sodium Chloride 0.9% Potassium Chloride 2%
Typical Use IV therapy, hypocalcemia Fluid replenishment Hyperkalemia management
Concentration 10% (100 mg/mL) 0.9% (9 mg/mL) 2% (20 mg/mL)
Cost Mid-range Low Mid-range
Storage Stable, moisture-sensitive Very stable Stable
Side Effects Hypercalcemia risk Hyponatremia Hyperkalemia risk

Note: Choice depends on clinical context and patient needs.


Future Outlook & Market Opportunities

  • Market Penetration in Emerging Markets: Expected to grow by 12% in Asia-Pacific due to increasing healthcare access.
  • Industrial Diversification: Expansion into de-icing tech and water purification in North America and Europe.
  • Product Innovation: Development of concentrated or stabilized formulations reducing volume requirements.
  • Regulatory Advances: Clearer pathways to approval could accelerate market entries and innovations.

Risks and Uncertainties

  • Economic downturns impacting healthcare budgets.
  • Variability in raw material prices.
  • Stringent regulatory revisions delaying approvals.
  • Competition from alternative therapies and solutions.

Key Takeaways

  • The calcium chloride 10% market is poised for steady growth, primarily driven by expanding healthcare infrastructure, especially in emerging economies.
  • Clinical applications remain the dominant revenue segment, but industrial uses like de-icing and water treatment are expanding.
  • Regulatory compliance and quality standards are critical for market entrants and existing suppliers.
  • Innovation in formulation and delivery methods will influence future market share and pricing strategies.
  • Supply chain resilience and raw material cost management are essential for maintaining profitability.

FAQs

1. What are the primary medical indications for calcium chloride 10% solutions?
Used predominantly in IV therapy for hypocalcemia correction, cardiac resuscitation, and arrhythmia management.

2. How does the industrial use of calcium chloride 10% impact the market?
Industrial applications, such as de-icing and water treatment, provide diversified revenue streams and are growing with infrastructure development.

3. What are the main challenges in manufacturing calcium chloride solutions?
Raw material variability, maintaining strict quality standards, and managing supply chain disruptions.

4. How do regulatory policies influence market growth?
Approval processes and quality requirement standards affect entry barriers and operational costs, influencing overall market expansion.

5. What future innovations are expected to impact calcium chloride 10% solutions?
Enhanced formulation stability, advanced delivery systems, and sustainable manufacturing practices are key areas.


References

[1] MarketWatch, “Global Calcium Chloride Market Size, Share & Trends Analysis Report,” 2022.
[2] Global Industry Analysts, Inc., “Calcium Chloride – A Global Market Outlook,” 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.